Universal Vision Biotechnology Co

Universal Vision Biotechnology Co EBIT per Share

The EBIT per Share of Universal Vision Biotechnology Co (3218.TWO) as of Oct 19, 2026 is 16.25 TWD. In the previous year, EBIT per Share was 16.51 TWD — a change of -1.57% (lower).

EBIT per Share

16.25TWD

YoY

-1.57%

Last updated:

EBIT per Share of Universal Vision Biotechnology Co is 2025 16.25 TWD. EBIT per Share of Universal Vision Biotechnology Co was 2024 16.51 TWD. It decreases by -1.57% lower compared to the previous year.

The Universal Vision Biotechnology Co EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2020
8.05 TWD
Jan 1, 2021
10.20 TWD
Jan 1, 2022
13.11 TWD
Jan 1, 2023
15.74 TWD
Jan 1, 2024
16.51 TWD
Jan 1, 2025
16.25 TWD
Jan 1, 2026 (e)
17.10 TWD
Jan 1, 2027 (e)
18.72 TWD
The Universal Vision Biotechnology Co EBIT per Share history
YEAREBIT per ShareYoY
est18.72TWD+9.47%
est17.10TWD+5.21%
16.25TWD-1.57%
16.51TWD+4.89%
15.74TWD+20.08%
13.11TWD+28.51%
10.20TWD+26.67%
8.05TWD+148.17%
3.25TWD+76.73%
1.84TWD+8.39%
1.69TWD-33.47%
2.55TWD+23.34%
2.06TWD-6.03%
2.20TWD+9.28%
2.01TWD+129.15%
0.88TWD+2,796.82%
0.03TWD-98.14%
1.63TWD-14.58%
1.91TWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Universal Vision Biotechnology Co Stock analysis

What does Universal Vision Biotechnology Co do? Universal Vision Biotechnology Co Ltd, listed on the Taiwan Stock Exchange under ticker 3218.TWO, is a company operating in the Health Care sector. Headquartered in Taipei City, Taiwan, the company has 404 employees. It went public on January 29, 2004. Universal Vision Biotechnology focuses on the sale of optical instruments, glasses, and contact lenses. The company also provides laser vision correction equipment and services, as well as medical cosmetology services. Its operations are primarily concentrated in the Taiwan market. The company's website is https://www.eyedoctor.com.tw/. Universal Vision Biotechnology does not engage in the sale of glass ornaments or the trading of medical drugs, as these details were incorrectly mentioned in the source description. The company is involved in the leasing of medical facilities and the planning of clinic operations, but it does not provide services related to the leasing of medical places or the trading of medical drugs. The company's business activities are centered around optical and medical services within Taiwan. Universal Vision Biotechnology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Universal Vision Biotechnology Co stock

EBIT per Share of Universal Vision Biotechnology Co is 16.25 TWD in 2025.

EBIT per Share of Universal Vision Biotechnology Co changed from 16.51 TWD to 16.25 TWD, representing a -1.57% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Universal Vision Biotechnology Co since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Universal Vision Biotechnology Co

All Key Metrics — Universal Vision Biotechnology Co